RT Journal Article
T1 COSMIC project: consensus on the objectives of the metabolic syndrome in clinic.
A1 Pedro-Botet, Juan
A1 Ascaso, Juan F
A1 Barrios, Vivencio
A1 De la Sierra, Alejandro
A1 Escalada, Javier
A1 Millán, Jesús
A1 Mostaza, Jose M
A1 Pérez-Martínez, Pablo
A1 Pintó, Xavier
A1 Salas-Salvadó, Jordi
A1 Valdivielso, Pedro
K1 cardiovascular prevention
K1 diabetes prevention
K1 dyslipidemia
K1 hypertension
K1 insulin resistance
K1 obesity
AB Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making.
SN 1178-7007
YR 2018
FD 2018-10-31
LK https://hdl.handle.net/10668/28331
UL https://hdl.handle.net/10668/28331
LA en
DS RISalud
RD Apr 11, 2025